Health related quality of life scales in women diagnosed with gynecological and breast cancer: The role of resilience. A systematic review
Resumen: Objective: Resilience and health-related quality of life are factors to be valued today in all types of patients for their relationship to well-being and health. Any stressful situation can significantly impact quality of life and resilience and there are numerous scales to rate these aspects. The main objective of this review is to describe the most used health-related quality of life and resilience scales in gynecological and breast cancer patients to highlight the limitations. Data sources: A review of literature in Pubmed, MEDLINE, Cochrane Database and Google Scholar was carried out to identify articles on health-related quality of life in oncological patients published in English between 2000 and 2020. Methods of study selection: The review was done following the PRISMA guidelines. Tabulation: A total of 460 papers were identified using MeSH terms but finally, according to the inclusion and exclusion criteria, we evaluated 41. Integration and results: Questionnaires have a good performance to quantify quality of life and resilience in oncological patients in general. However, most publications were not focused on patients with gynecological cancer. Conclusions: Due to the particularities of the group of patients with gynecologic and breast cancer secondary to their treatment significantly affecting several areas and domains, it is necessary to validate specific scales for them in order to offer these patients the correct management of their disease at all levels. The role of resilience, premature and iatrogenic menopause and mutilating surgeries are essential to understand the uniqueness of health-related quality of life in gynecological and breast cancer patients. ©2021 The Author(s).
Idioma: Inglés
DOI: 10.31083/j.ejgo4205154
Año: 2021
Publicado en: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY 42, 5 (2021), 1048-1057
ISSN: 0392-2936

Factor impacto JCR: 0.255 (2021)
Categ. JCR: ONCOLOGY rank: 243 / 245 = 0.992 (2021) - Q4 - T3
Categ. JCR: OBSTETRICS & GYNECOLOGY rank: 83 / 85 = 0.976 (2021) - Q4 - T3

Factor impacto SCIMAGO: 0.0 - Oncology - Obstetrics and Gynecology

Tipo y forma: Article (Published version)
Área (Departamento): Área Obstetricia y Ginecología (Dpto. Cirugía)
Exportado de SIDERAL (2023-05-18-16:14:12)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
articulos



 Notice créée le 2022-02-10, modifiée le 2023-05-19


Versión publicada:
 PDF
Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)